A comparison of a new graduated formulation with three constant-dosed oral contraceptives
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 35 (6) , 523-532
- https://doi.org/10.1016/s0010-7824(87)80013-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1982
- Oral contraceptives, clotting factors, and thrombosisAmerican Journal of Obstetrics and Gynecology, 1982
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ringAmerican Journal of Obstetrics and Gynecology, 1980
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Three-Year Prospective Study of Carbohydrate Metabolism in Women Using OvulenSouthern Medical Journal, 1977
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975
- A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activityContraception, 1974